Next Article in Journal
Real-Time Monitoring of Powder Mixing Dynamics with Spectroscopic PAT-Tools
Previous Article in Journal
Effect of High-Pressure Homogenization on the Formulation of Micro- and Nanocrystals Containing Poorly Watersoluble Meloxicam
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Conference Report

Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework

1
Malvern Instruments, Malvern, United Kingdom
2
Malvern Instruments, Westborough, MA, USA
3
Malvern Instruments, Orsay, France
*
Authors to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 572; https://doi.org/10.3797/scipharm.cespt.8.LPAT01
Submission received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The availability and use of appropriate Process Analytical Technology (PAT) is fundamental to achieving the transformed style of pharmaceutical manufacture that is envisaged by the regulators. [...]

Share and Cite

MDPI and ACS Style

LOOSER, B.; VAISMAN, A.; BLASCO, A. Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework. Sci. Pharm. 2010, 78, 572. https://doi.org/10.3797/scipharm.cespt.8.LPAT01

AMA Style

LOOSER B, VAISMAN A, BLASCO A. Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework. Scientia Pharmaceutica. 2010; 78(3):572. https://doi.org/10.3797/scipharm.cespt.8.LPAT01

Chicago/Turabian Style

LOOSER, B., A. VAISMAN, and A. BLASCO. 2010. "Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework" Scientia Pharmaceutica 78, no. 3: 572. https://doi.org/10.3797/scipharm.cespt.8.LPAT01

Article Metrics

Back to TopTop